These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 14598053)

  • 1. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
    Comi G; Quattrini A; Fazio R; Roveri L
    Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    Van Doorn PA
    Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?
    Alexandrescu DT; Dutcher JP; Hughes JT; Kaplan J; Wiernik PH
    Am J Hematol; 2005 Mar; 78(3):216-20. PubMed ID: 15726606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of chronic inflammatory demyelinating polyneuropathy].
    Lünemann JD; Prass K; Zschenderlein R
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):672-8. PubMed ID: 15580532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin treatment in three children with chronic inflammatory demyelinating neuropathy.
    Hergüner MO; Incecik F; Altunbaşak S
    Pediatr Neurol; 2009 Sep; 41(3):223-5. PubMed ID: 19664543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy.
    Zinman LH; Sutton D; Ng E; Nwe P; Ngo M; Bril V
    Transfus Apher Sci; 2005 Nov; 33(3):317-24. PubMed ID: 16239123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocardial infarction following intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy in association with a monoclonal immunoglobulin G paraprotein.
    Stamboulis E; Theodorou V; Kilidireas K; Apostolou T
    Eur Neurol; 2004; 51(1):51. PubMed ID: 14639034
    [No Abstract]   [Full Text] [Related]  

  • 14. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
    Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
    Remiche G; Kentos A; Mavroudakis N
    Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):38-42. PubMed ID: 7964851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy.
    Comi G; Roveri L; Swan A; Willison H; Bojar M; Illa I; Karageorgiou C; Nobile-Orazio E; van den Bergh P; Swan T; Hughes R; Aubry J; Baumann N; Hadden R; Lunn M; Knapp M; Léger JM; Bouche P; Mazanec R; Meucci N; van der Meché F; Toyka K;
    J Neurol; 2002 Oct; 249(10):1370-7. PubMed ID: 12382151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.